A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Condition(s):Metastatic Colorectal CancerLast Updated:June 29, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Colorectal CancerLast Updated:June 29, 2021Terminated
Condition(s):Neurofibromatosis Type 2; Progressive Vestibular SchwannomasLast Updated:February 12, 2021Completed
Condition(s):Alzheimer’s DiseaseLast Updated:May 3, 2023Active, not recruiting
Condition(s):Endometrial CancerLast Updated:July 31, 2018Completed
Condition(s):ObesityLast Updated:January 27, 2020Completed
Condition(s):Colorectal NeoplasmsLast Updated:September 18, 2017Terminated
Condition(s):BronchiectasisLast Updated:January 24, 2018Completed
Condition(s):Central Precocious PubertyLast Updated:July 28, 2017Completed
Condition(s):HyperlipidemiaLast Updated:July 20, 2020Completed
Condition(s):Alzheimers Disease; Dementia; Alzheimers Disease, FamilialLast Updated:October 10, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.